Drugs / PG4 Multivalent Vaccine
last change Sep 2026 re-read 9 days ago

PG4 Multivalent Vaccine

Vaccine

Developed for
pneumococcal infection
Investigated by
Pfizer

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07794748 Sep 2026 → Jun 2027 expected pneumococcal infection Pfizer Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PG4 Multivalent Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT07794748 ↗
Modality Vaccine “Multivalent Pneumococcal Vaccine” NCT07794748 ↗